Coherus Oncology, Inc. financial data

Symbol
CHRS on Nasdaq
Location
Redwood City, CA
Fiscal year end
31 December
Latest financial report
09 Mar 2026

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 132% % 9.7%
Quick Ratio 1.3% % -88%
Debt-to-equity 1762% %
Return On Assets 42% % 789%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 149,889,902 shares 29%
Common Stock, Shares, Outstanding 121,154,925 shares 4.8%
Entity Public Float $81,900,000 USD -52%
Common Stock, Value, Issued $12,000 USD 0%
Weighted Average Number of Shares Outstanding, Basic 117,143,457 shares 2.3%
Weighted Average Number of Shares Outstanding, Diluted 117,143,457 shares 2.3%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense $108,888,000 USD 19%
Costs and Expenses $223,306,000 USD -1.2%
Operating Income (Loss) $181,134,000 USD 9.3%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $183,124,000 USD 15%
Net Income (Loss) Attributable to Parent $168,024,000 USD 489%
Earnings Per Share, Basic 1.43 USD/shares 472%
Earnings Per Share, Diluted 1.43 USD/shares 472%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $88,879,000 USD -29%
Marketable Securities, Current $83,246,000 USD
Inventory, Net $3,172,000 USD -25%
Assets, Current $206,706,000 USD -39%
Property, Plant and Equipment, Net $1,345,000 USD -48%
Operating Lease, Right-of-Use Asset $2,953,000 USD -35%
Other Assets, Noncurrent $4,053,000 USD -38%
Assets $258,343,000 USD -42%
Accounts Payable, Current $9,915,000 USD -65%
Employee-related Liabilities, Current $14,579,000 USD -21%
Accrued Liabilities, Current $20,430,000 USD -66%
Liabilities, Current $140,386,000 USD -50%
Deferred Income Tax Liabilities, Net $1,102,000 USD 0%
Operating Lease, Liability, Noncurrent $1,457,000 USD -56%
Other Liabilities, Noncurrent $18,435,000 USD -37%
Liabilities $197,329,000 USD -66%
Accumulated Other Comprehensive Income (Loss), Net of Tax $195,000 USD 29%
Retained Earnings (Accumulated Deficit) $1,382,969,000 USD 11%
Stockholders' Equity Attributable to Parent $61,014,000 USD
Liabilities and Equity $258,343,000 USD -42%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $25,826,000 USD 45%
Net Cash Provided by (Used in) Financing Activities $264,000 USD -130%
Net Cash Provided by (Used in) Investing Activities $17,486,000 USD -109%
Common Stock, Shares Authorized 300,000,000 shares 0%
Common Stock, Shares, Issued 121,154,925 shares 4.8%
Common Stock, Par or Stated Value Per Share 0.0001 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $43,576,000 USD -128%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $89,119,000 USD -29%
Deferred Tax Assets, Valuation Allowance $368,124,000 USD -11%
Deferred Tax Assets, Gross $375,552,000 USD -10%
Operating Lease, Liability $3,285,000 USD -34%
Lessee, Operating Lease, Liability, to be Paid $3,656,000 USD -37%
Operating Lease, Liability, Current $1,828,000 USD 8.1%
Lessee, Operating Lease, Liability, to be Paid, Year Two $1,530,000 USD -28%
Lessee, Operating Lease, Liability, to be Paid, Year One $2,126,000 USD -3%
Operating Lease, Weighted Average Discount Rate, Percent 0.121 pure 1.7%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $371,000 USD -57%
Lessee, Operating Lease, Liability, to be Paid, Year Three $1,530,000 USD -28%
Deferred Tax Assets, Operating Loss Carryforwards $174,237,000 USD 10%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 5,000,000 shares 0%
Unrecognized Tax Benefits $20,017,000 USD 4%
Additional Paid in Capital $1,444,166,000 USD 1.8%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets $2,600,000 USD -24%
Depreciation, Depletion and Amortization $1,300,000 USD -19%
Deferred Tax Assets, Net of Valuation Allowance $7,428,000 USD 18%
Share-based Payment Arrangement, Expense $16,966,000 USD -39%
Interest Expense $9,001,000 USD -16%
Preferred Stock, Par or Stated Value Per Share 0.0001 USD/shares 0%